Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDKN1B Antikörper

Der Maus Monoklonal Anti-CDKN1B-Antikörper wurde für ELISA validiert. Er ist geeignet, CDKN1B in Proben von Human zu detektieren. Es sind 2+ Publikationen verfügbar.
Produktnummer ABIN969044

Kurzübersicht für CDKN1B Antikörper (ABIN969044)

Target

Alle CDKN1B Antikörper anzeigen
CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))

Reaktivität

  • 283
  • 134
  • 120
  • 34
  • 8
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 237
  • 60
  • 2
  • 1
  • 1
Maus

Klonalität

  • 226
  • 75
Monoklonal

Konjugat

  • 157
  • 20
  • 16
  • 13
  • 13
  • 11
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser CDKN1B Antikörper ist unkonjugiert

Applikation

  • 204
  • 127
  • 78
  • 70
  • 59
  • 41
  • 38
  • 34
  • 26
  • 16
  • 16
  • 14
  • 7
  • 7
  • 4
  • 3
  • 1
  • 1
  • 1
ELISA

Klon

3D8
  • Verwendungszweck

    CDKN1B Antibody

    Aufreinigung

    Ascitic fluid

    Immunogen

    Purified recombinant fragment of human CDKN1B expressed in E. Coli.

    Isotyp

    IgG1
  • Applikationshinweise

    ELISA: 1/10000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Ascitic fluid containing 0.03 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Lee, Kim: "The function of p27 KIP1 during tumor development." in: Experimental & molecular medicine, Vol. 41, Issue 11, pp. 765-71, (2009) (PubMed).

    Duncan, Al-Attar, Rolland, Harper, Spendlove, Durrant: "Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer." in: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, Vol. 29, Issue 1, pp. 8-18, (2009) (PubMed).

  • Target

    CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))

    Andere Bezeichnung

    CDKN1B

    Hintergrund

    P27 KIP 1 is a cell cycle regulatory mitotic inhibitor of cdk activity. p27 KIP 1 is a candidate tumor suppressor gene, and has been proposed to function as a possible mediator of TGF beta induced G1 arrest. p27 KIP 1 is up regulated in response to antimitogenic stimuli. The increased protein expression of p27 results in cellular arrest by binding to cyclin/Cdk complexes such as cyclin D1/Cdk4. Decreased levels of p27Kip1, mainly due to proteosomal degradation, are found in various epithelial tumors originating from lung, breast, colon, ovary, esophagus, thyroid and prostate.Tissue specificity: Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney.

    Molekulargewicht

    22 kDa

    UniProt

    P46527

    Pathways

    Zellzyklus, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Sensory Perception of Sound, Mitotic G1-G1/S Phases, DNA Replication, Positive Regulation of Endopeptidase Activity, Synthesis of DNA, Autophagie
Sie sind hier:
Chat with us!